{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:08Z","timestamp":1786120268131,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/rlu.0b013e3182291a7b","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T03:13:36Z","timestamp":1317784416000},"page":"991-996","source":"Crossref","is-referenced-by-count":30,"title":["Quantitative Evaluation of Striatal I-123-FP-CIT Uptake in Essential Tremor and Parkinsonism"],"prefix":"10.1097","volume":"36","author":[{"given":"Gemma","family":"Cuberas-Borr\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Lorenzo-Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Aguad\u00e9-Bruix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Hern\u00e1ndez-Vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Pifarr\u00e9-Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"\u00c1lvarez-Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Castell-Conesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson's disease severity and duration with I-123-FP-CIT SPECT striatal uptake.","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","article-title":"Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"R3-5-20210204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0025-7753(04)74224-4","article-title":"Differential diagnosis of parkinsonism using dopamine transporters brain SPECT.","volume":"122","author":"Lorenzo Bosquet","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/sleep\/26.5.507","article-title":"Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.","volume":"26","author":"Eisensehr","year":"2003","journal-title":"Sleep"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.1049","article-title":"Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell.","volume":"50","author":"Berendse","year":"2001","journal-title":"Ann Neurol"},{"key":"R6-5-20210204","first-page":"10","article-title":"Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs [in Spanish].","volume":"11","author":"Mart\u00ed Mass\u00f3","year":"1996","journal-title":"Neurologia"},{"key":"R7-5-20210204","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/mds.10575","article-title":"DAT imaging in drug-induced and psychogenic parkinsonism.","volume":"18","author":"Tolosa","year":"2003","journal-title":"Mov Disord"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"R9-5-20210204","first-page":"131","article-title":"Automated Talairach atlas labels for functional brain mapping. Hum.","volume":"120-","author":"Lancaster","year":"10","journal-title":"Brain Mapp"},{"key":"R10-5-20210204","first-page":"244","article-title":"Quantitative evaluation of 123I-FP-CIT SPECT: validation of a semiautomated method.","volume":"24","author":"Lorenzo Bosquet","year":"2005","journal-title":"Rev Esp Med Nucl"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuroimage.2004.06.045","article-title":"The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.","volume":"23","author":"Colloby","year":"2004","journal-title":"Neuroimage"},{"key":"R12-5-20210204","first-page":"1109","article-title":"Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.","volume":"46","author":"Koch","year":"2005","journal-title":"J Nucl Med"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mds.21505","article-title":"Role of DAT-SPECT in the diagnostic work up of parkinsonism.","volume":"22","author":"Scherfler","year":"2007","journal-title":"Mov Disord"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00259-009-1289-4","article-title":"Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease.","volume":"37","author":"Diaz-Corrales","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-5-20210204","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/jnnp.2004.045237","article-title":"How useful is [123I]\u03b2-CIT SPECT in clinical practice?","volume":"76","author":"Eerola","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R16-5-20210204","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00702-005-0401-6","article-title":"Possible impact of dopamine SPECT on decision-making for drug treatment in parkinsonian syndrome.","volume":"113","author":"Hesse","year":"2006","journal-title":"J Neural Transm"},{"key":"R17-5-20210204","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000115640","article-title":"Diagnostic value of I-ioflupane and (123)I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.","volume":"59","author":"Vlaar","year":"2008","journal-title":"Eur Neurol"},{"key":"R18-5-20210204","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","article-title":"Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs.","volume":"35","author":"Booij","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R19-5-20210204","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1160\/nukmed-0037","article-title":"Equipment-independent reference values for dopamine transporter imaging with 123I-FP-CIT.","volume":"46","author":"Koch","year":"2007","journal-title":"Nuklearmedizin"},{"key":"R20-5-20210204","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","article-title":"Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects.","volume":"12","author":"Muller-Gartner","year":"1992","journal-title":"J Cereb Blood Flow Metab"},{"key":"R21-5-20210204","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation.","volume":"39","author":"Rousset","year":"1998","journal-title":"J Nucl Med"},{"key":"R22-5-20210204","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/RLU.0b013e318156bbb9","article-title":"Can I-123-FP-CIT images give us a clue that implies a vascular parkinsonism?","volume":"32","author":"Mil\u00e0","year":"2007","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-201111000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:24:30Z","timestamp":1786047870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-201111000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e3182291a7b","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}